Next Generation Sequencing Informatics Market Overview:
The next-generation sequencing informatics market was estimated at USD 1.263.50 million in 2018 and is expected to achieve USD 3.210.56 million by 2024, with an anticipated CAGR of 16.92 percent during the forecast period 2019-2024 .
The primary factors driving the development of the market are the increasing clinical applications of next-generation sequencing NGS, technological advances in NGS informatics instruments, increasing preference for personalized drugs and early disease diagnosis, and increasing demand from important players for NGS services and investments. Applications include full genome and transcriptome sequencing, metagenomic characterization of microbial kinds in environmental and clinical samples, explanation of DNA binding locations for chromatin and regulatory proteins, and targeted re-sequencingof particular locations in the human genome, recognized through linkage analyzes. The unavailability of qualified experts for analyzing and interpreting NGS information, along with the absence of understanding of fresh informatics instruments among medical practitioners, is likely to restrict the development of the researched industry. In addition, high costs associated with the maintenance and safety of computer instruments are probable to contribute to the limitation.
Get a FREE sample copy of this report now! https://www.planetmarketreports.com/report-sample/next-generation-sequencing-informatics-market-size-outlook-growth-trends-and-forecasts-2026
Scope of the Report:
The next-generation sequencing NGS informatics market henceforth referred to as the market studied involves multiple kinds of sequencing facilities that fuelled the implementation of new techniques that provide great opportunities for low-cost and quick DNA sequencing.
Key Market Trends:
Genetic Screening Segment is expected to experience the largest share over the forecast period.
There are several companies in the market that provide NGS facilities for a spectrum of genetic disorders and testing of DNA, RNA, and specific samples such as T-cells and B-cells, such as MedGenome. In clinical medical genetics records, huge parallel sequencing is required for molecular diagnosis to detect hereditary genetic defects. There are numerous publicly accessible single nuclear polymorphism SNP databases, population allele frequency, and feature prediction computational algorithms for the identification of a majority of variations in genetic screening for the evaluation of exome sequencing.
There is a high range of technological improvements in the application of NGS in genetic testing. Mayo Clinic developed a 50-gene cancer panel test CANCP in 2014 to help tailor chemotherapy based on the unique genome signature of the tumor of each patient. Recently, genetic screening and interpretation based on NGS have been helpful in improving hearing loss testing. Recently, according to an article released in 2018 in the Journal of Fertility and Sterility, pre-implantation genetic screening using NGS considerably enhanced pregnancy results compared to a range of comparative genomic hybridization. Therefore, NGS has a huge amount of diverse applications through genetic screening in various illnesses, but their affordability and accessibility in high-income and low-income countries may vary a lot. In the forecast period, therefore, steady growth is anticipated.
Get Full Reports Access – https://www.planetmarketreports.com/reports/next-generation-sequencing-informatics-market-size-outlook-growth-trends-and-forecasts-2026
North America is dominating the market growth
North America is anticipated to dominate the overall market over the forecast period. The presence of high per capita healthcare expenditures, combined with high patient awareness rates and high target disease prevalence, contributes to the growth of the region s market. The United States maintains the biggest market share in the North American region.
Competitive Landscape:
The informatics sequencing market of the next generation is moderately competitive and consists of several significant players. With regard to market share, few of the major players presently dominate the market. With increasing patient awareness rates and elevated target disease prevalence, few other smaller players are anticipated to join the market. Some of the market s main players are Agilent Technologies Inc., Amazon Web Services Inc., F. Hoffmann-La Roche Ltd., Intrexon Bioinformatics Germany GmbH, and Illumina Inc., among others.
About Us :-
Planet Market Reports gives statistical surveying reports to businesses, people and associations with a goal of helping them in their decision-making process. We have a huge database of market research reports & company profiles across the globe. We offer premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Planet Market Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, & industry experts which provide you deeper penetration of market research industry ensuring you will receive the most reliable and up to date research data available.
Contact US:-
Name: Jennifer Daniel
Email-Id: sales@planetmarketreports.com
US : +1-716-2260907
UK : +447441952057
Organization: Planet Market Reports